日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/03 | 7,530 | 7,610 | 7,490 | 7,580 | -30 | -0.4% | 111,200 |
| 2022/02/02 | 7,470 | 7,640 | 7,470 | 7,610 | +120 | +1.6% | 118,600 |
| 2022/02/01 | 7,550 | 7,660 | 7,470 | 7,490 | +20 | +0.3% | 106,500 |
| 2022/01/31 | 7,470 | 7,520 | 7,390 | 7,470 | ±0 | ±0% | 189,000 |
| 2022/01/28 | 7,510 | 7,640 | 7,400 | 7,470 | -70 | -0.9% | 189,800 |
| 2022/01/27 | 7,600 | 7,610 | 7,500 | 7,540 | -130 | -1.7% | 181,900 |
| 2022/01/26 | 7,630 | 7,750 | 7,610 | 7,670 | +70 | +0.9% | 242,300 |
| 2022/01/25 | 7,400 | 7,630 | 7,340 | 7,600 | +150 | +2% | 218,000 |
| 2022/01/24 | 7,260 | 7,490 | 7,250 | 7,450 | +100 | +1.4% | 135,200 |
| 2022/01/21 | 7,420 | 7,440 | 7,320 | 7,350 | -70 | -0.9% | 175,000 |
| 2022/01/20 | 7,260 | 7,490 | 7,260 | 7,420 | +160 | +2.2% | 173,200 |
| 2022/01/19 | 7,470 | 7,500 | 7,260 | 7,260 | -320 | -4.2% | 181,300 |
| 2022/01/18 | 7,730 | 7,740 | 7,570 | 7,580 | -70 | -0.9% | 92,200 |
| 2022/01/17 | 7,670 | 7,780 | 7,630 | 7,650 | +10 | +0.1% | 82,700 |
| 2022/01/14 | 7,720 | 7,770 | 7,530 | 7,640 | -140 | -1.8% | 179,200 |
| 2022/01/13 | 7,900 | 7,910 | 7,760 | 7,780 | -190 | -2.4% | 127,400 |
| 2022/01/12 | 7,880 | 8,010 | 7,860 | 7,970 | +190 | +2.4% | 141,600 |
| 2022/01/11 | 7,830 | 7,870 | 7,710 | 7,780 | -10 | -0.1% | 171,800 |
| 2022/01/07 | 7,840 | 7,920 | 7,760 | 7,790 | -100 | -1.3% | 157,500 |
| 2022/01/06 | 7,870 | 7,920 | 7,840 | 7,890 | -70 | -0.9% | 168,800 |
| 2022/01/05 | 7,990 | 8,060 | 7,920 | 7,960 | -70 | -0.9% | 198,800 |
| 2022/01/04 | 8,060 | 8,070 | 7,920 | 8,030 | +20 | +0.2% | 133,400 |
| 2021/12/30 | 8,030 | 8,110 | 8,010 | 8,010 | -80 | -1% | 79,400 |
| 2021/12/29 | 8,210 | 8,210 | 7,970 | 8,090 | -120 | -1.5% | 144,000 |
| 2021/12/28 | 8,120 | 8,260 | 8,090 | 8,210 | +90 | +1.1% | 91,100 |
| 2021/12/27 | 8,100 | 8,160 | 8,070 | 8,120 | ±0 | ±0% | 61,500 |
| 2021/12/24 | 8,190 | 8,210 | 8,050 | 8,120 | -60 | -0.7% | 99,500 |
| 2021/12/23 | 8,330 | 8,340 | 8,150 | 8,180 | -40 | -0.5% | 109,900 |
| 2021/12/22 | 8,120 | 8,220 | 8,080 | 8,220 | +100 | +1.2% | 178,500 |
| 2021/12/21 | 8,100 | 8,190 | 8,040 | 8,120 | +160 | +2% | 149,100 |
| 2021/12/20 | 7,790 | 7,960 | 7,780 | 7,960 | +110 | +1.4% | 155,700 |
| 2021/12/17 | 8,080 | 8,120 | 7,800 | 7,850 | -270 | -3.3% | 266,800 |
| 2021/12/16 | 8,120 | 8,170 | 8,080 | 8,120 | +80 | +1% | 128,000 |
| 2021/12/15 | 8,020 | 8,120 | 8,010 | 8,040 | -50 | -0.6% | 134,400 |
| 2021/12/14 | 8,100 | 8,210 | 8,080 | 8,090 | ±0 | ±0% | 134,700 |
| 2021/12/13 | 8,210 | 8,240 | 8,080 | 8,090 | +10 | +0.1% | 109,100 |
| 2021/12/10 | 8,200 | 8,210 | 8,060 | 8,080 | -130 | -1.6% | 137,400 |
| 2021/12/09 | 8,260 | 8,340 | 8,210 | 8,210 | -200 | -2.4% | 97,300 |
| 2021/12/08 | 8,500 | 8,560 | 8,380 | 8,410 | +60 | +0.7% | 183,900 |
| 2021/12/07 | 8,130 | 8,380 | 8,080 | 8,350 | +200 | +2.5% | 130,500 |
| 2021/12/06 | 8,210 | 8,300 | 8,140 | 8,150 | -70 | -0.9% | 104,500 |
| 2021/12/03 | 8,130 | 8,220 | 8,040 | 8,220 | +60 | +0.7% | 170,700 |
| 2021/12/02 | 8,190 | 8,260 | 8,160 | 8,160 | -70 | -0.9% | 174,100 |
| 2021/12/01 | 8,360 | 8,390 | 8,160 | 8,230 | -170 | -2% | 245,500 |
| 2021/11/30 | 8,520 | 8,660 | 8,400 | 8,400 | -120 | -1.4% | 467,500 |
| 2021/11/29 | 8,620 | 8,690 | 8,490 | 8,520 | -90 | -1% | 161,500 |
| 2021/11/26 | 8,810 | 8,860 | 8,540 | 8,610 | -200 | -2.3% | 124,400 |
| 2021/11/25 | 8,770 | 8,920 | 8,710 | 8,810 | +110 | +1.3% | 110,900 |
| 2021/11/24 | 8,650 | 8,720 | 8,590 | 8,700 | -60 | -0.7% | 110,800 |
| 2021/11/22 | 8,620 | 8,800 | 8,600 | 8,760 | +140 | +1.6% | 96,100 |
851～
900
件表示中 / 3749件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 319,900円 | +8.0% | -15.3% | 3.88% | 8.98倍 | 0.87倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 398,200円 | +5.8% | +1.2% | 3.01% | 12.89倍 | 1.03倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 366,000円 | +3.8% | -19.9% | 3.72% | 11.89倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 194,200円 | +5.9% | +684.6% | 2.83% | 12.89倍 | 1.29倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 171,200円 | +5.0% | +1.5% | 0.00% | 14.64倍 | 3.90倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
